IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction.
about
Engineering mesenchymal stem cells for regenerative medicine and drug deliveryTLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotection.Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure.Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injurySca-1+ cardiac stem cells mediate acute cardioprotection via paracrine factor SDF-1 following myocardial ischemia/reperfusionInterleukin-18 induces EMMPRIN expression in primary cardiomyocytes via JNK/Sp1 signaling and MMP-9 in part via EMMPRIN and through AP-1 and NF-kappaB activationGenetic engineering of mesenchymal stem cells and its application in human disease therapy.Cardiorenal syndromes: pathophysiology to preventionAnimal models of cardiac disease and stem cell therapy.EMMPRIN activates multiple transcription factors in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF-kappaB andMKK7/JNK/AP-1 signaling.Genetic variant in interleukin-18 is associated with idiopathic recurrent miscarriage in Chinese Han populationParacrine effect of Wnt11-overexpressing mesenchymal stem cells on ischemic injury.The secretome of myocardial telocytes modulates the activity of cardiac stem cells.Penehyclidine Hydrochloride Preconditioning Provides Cardioprotection in a Rat Model of Myocardial Ischemia/Reperfusion Injury.Sensing the cardiac environment: exploiting cues for regenerationLipopolysaccharide treatment induces genome-wide pre-mRNA splicing pattern changes in mouse bone marrow stromal stem cells.Knockdown of EMMPRIN improves adverse remodeling mediated by IL-18 in the post-infarcted heartALDH2 activator inhibits increased myocardial infarction injury by nitroglycerin tolerance.Mesenchymal stem cell-based therapy.Role of IL-18 in second-hand smoke-induced emphysemaIschemia/Reperfusion injury protection by mesenchymal stem cell derived antioxidant capacity.The potential of stem cells in the treatment of cardiovascular diseases.Attenuated recovery of contractile function in aging hearts following global ischemia/reperfusion: Role of extracellular HSP27 and TLR4.Optimizing stem cell function for the treatment of ischemic heart diseaseThe immunomodulatory properties of mesenchymal stem cells: implications for surgical disease.Anti-inflammatory mechanisms and therapeutic opportunities in myocardial infarct healing.Cardiac cell therapy: boosting mesenchymal stem cells effects.The role of the inflammasome in cardiovascular diseases.Bone marrow-derived mesenchymal stem cells for the treatment of heart failure.Interleukin-1 in cardiac injury, repair, and remodeling: pathophysiologic and translational conceptsTargeting danger-associated molecular patterns after myocardial infarction.IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κB.Controlled Inhibition of the Mesenchymal Stromal Cell Pro-inflammatory Secretome via Microparticle Engineering.Interleukin-18: Biological properties and role in disease pathogenesis.The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction.Distinct patterns of histone modifications at cardiac-specific gene promoters between cardiac stem cells and mesenchymal stem cells.Tracking long-term survival of intramyocardially delivered human adipose tissue-derived stem cells using bioluminescence imaging.Platelet-derived growth factor-BB enhances MSC-mediated cardioprotection via suppression of miR-320 expression.Stem cells as delivery vehicles for regenerative medicine-challenges and perspectives.
P2860
Q27026414-DC0BCB56-C129-4FA7-AE86-CC783A02DDBFQ33769592-15287D4D-41B7-4D6F-A9BD-B7DB4C109E7CQ33801215-91365CBA-4D9C-4C64-BE48-9372D9EBD268Q33840741-A9A9B7F2-E869-4574-A7A2-DF6852030828Q34110874-620154EF-1AFA-4FBF-B0BC-CEEDECD5625DQ34212169-5B0A830F-3107-4947-B91C-FB0B372AACA9Q34298871-7AD692E7-E05B-42F0-B915-9D21ADB502CAQ34373061-03A79E26-A234-4EAD-8C52-B5BA11F6DC9DQ34508351-A53AE892-314E-4EED-A470-6BA4951CDE8DQ34591446-20B21A17-3BB9-4D6C-BB54-D5B1DD4F67B0Q35139217-9818560A-2A5B-416A-B5B1-431FBC76E17BQ35167050-0E2CCE75-7D59-4415-ACF5-51A1C6CE174DQ35692203-53D9D199-DFA7-45F0-AD6C-791F2F2A912AQ35859797-58A43F59-DA6B-45BE-9027-0806506E2FEAQ35906866-A581D42D-ACBF-4250-8980-F758180F8976Q36111569-718D6BFD-5B53-4AA2-A004-B295C6C2EFD9Q36309504-D2CFE23E-123B-436D-83D1-48A0A9E6AEF7Q36541250-4704B5F2-605C-4F74-A506-F7B105BFD642Q36546424-471C84F3-DEAC-41B9-9A54-6329138D153DQ37056441-7A12CF6F-D389-483E-924A-311621BFF6E7Q37139569-2CA0EB8F-C595-4020-95F1-57AC8223DE99Q37325686-2D6C8596-5791-4B7D-8AF2-B288E9500BA5Q37604048-69C9A1FD-52EE-4C2B-8B7B-1F2F299A456DQ37786701-B83A50AC-F2B6-4A81-8796-3CE78845A200Q37792295-E1FC6291-6AFD-4295-8E1A-98DEBF4CB3E4Q37974118-42199F00-983B-48F1-9881-CEA4DFF35645Q37986552-8293E44F-7CB9-4C01-97E8-7BEACC77C44CQ38196722-8143972D-4511-47F5-BD8E-C242BBBB0E8EQ38214941-48723037-4067-4B3D-979E-39DBCC36A946Q38566665-FA11DC62-8D3F-4E4C-957B-F3CBD28A59DAQ38595544-FFBB933D-5227-49A4-8006-9E422EB2AA48Q40069845-A05CC27A-3D10-46AA-8E74-D2E65BFF4140Q42226608-F5E6638D-B044-4B0A-8427-C17487323378Q47285927-E867AB31-B6D7-4DA9-84CA-BBCC5D0C537FQ47288476-8D6FE3BD-1BC6-4D84-9AFC-8B0885F6F019Q48033062-4A48E063-151B-4765-8E31-5D9E5F04351CQ50542955-B481DEA3-6792-41E9-A8D1-0DB33830C5C3Q51003781-D6EF69A2-B97C-40E2-A2ED-214F73C2ADB3Q55400539-DD29B2F3-CC17-40EF-9F91-D8590E1370EC
P2860
IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
IL-18 binding protein-expressi ...... after ischemia or infarction.
@en
IL-18 binding protein-expressi ...... after ischemia or infarction.
@nl
type
label
IL-18 binding protein-expressi ...... after ischemia or infarction.
@en
IL-18 binding protein-expressi ...... after ischemia or infarction.
@nl
prefLabel
IL-18 binding protein-expressi ...... after ischemia or infarction.
@en
IL-18 binding protein-expressi ...... after ischemia or infarction.
@nl
P2093
P2860
P356
P1476
IL-18 binding protein-expressi ...... after ischemia or infarction.
@en
P2093
Daniel R Meldrum
Jiangning Tan
Kirstan K Meldrum
Meijing Wang
P2860
P304
17499-17504
P356
10.1073/PNAS.0908924106
P407
P577
2009-09-25T00:00:00Z